The research centers on a long-standing question in cancer biology: how does p53, the most frequently inactivated tumor suppressor in human cancers, actually suppress tumorigenesis? Decades of work in mammalian cells have catalogued dozens of p53-regulated genes, but the sheer complexity of mammalian genomes has made it difficult to assign specific tumor-suppressing functions to individual downstream effectors. Model organisms with simpler gene regulatory landscapes can help. In the fruit fly Drosophila melanogaster, the authors note, the primary transcriptional target of p53 is the gene encoding Xrp1, a transcription factor of the bZip AT-hook family. That simplicity makes the fly an unusually clean system for asking what a single p53 target gene actually accomplishes when the genome comes under attack.

The study’s first major finding is that Xrp1 is not merely one p53 target among many—it is a genuine mediator of p53’s functions in the DNA damage response, often abbreviated DDR. When the authors examined flies with reduced Xrp1 function, they found defects in p53-dependent gene transcription following DNA damage, indicating that Xrp1 feeds back into the transcriptional program that p53 initiates. They also found that Xrp1 contributes to p53-dependent apoptosis, the programmed cell death that eliminates severely damaged cells before they can propagate mutations. In other words, Xrp1 sits downstream of p53 and helps execute two of p53’s most important protective outputs: amplifying the damage-response transcriptional program and triggering the destruction of compromised cells.

But the story does not end with p53. Previous work had established a second, p53-independent role for Xrp1 in a phenomenon known as cell competition. Cell competition is a form of intercellular comparison in which cells that are less fit—because of mutations, defects in protein synthesis, or other suboptimal states—are actively eliminated by their more fit neighbors. Crucially, cell competition can remove cells whose genomes have been altered by DNA damage and subsequent repair, even after the acute damage response has subsided. This makes it a plausible second line of defense: where the DDR fails to fully restore a normal genome, competition may cull the imperfect cells from the tissue altogether.

To understand how Xrp1 is recruited into this second pathway, the authors turned to a protein called RpS12. During cell competition, Xrp1 is induced by RpS12, which acts as a sensor of defective ribosome biogenesis—the process by which cells build their protein-making machinery. Cells with compromised ribosome production or function trigger RpS12-dependent signaling, which in turn elevates Xrp1, marking them for elimination by their neighbors. This places Xrp1 at the hub of two distinct regulatory circuits: one routed through p53 in response to DNA strand breaks, and another routed through RpS12 in response to defects in the cellular protein synthesis apparatus.

The temporal relationship between these two circuits emerged as one of the most striking aspects of the study. The researchers irradiated developing fly tissues—specifically imaginal discs, the larval precursors of adult structures—and tracked Xrp1’s behavior over time. They found that the p53-independent, RpS12-dependent function of Xrp1 began only as the acute DNA damage response was coming to an end. In other words, the two pathways do not operate simultaneously; they are staged. First, the p53-dependent DDR confronts the damage directly, activating repair genes and apoptosis. Then, as that acute phase winds down, the RpS12-dependent competitive mechanism takes over, targeting any cells that remain abnormal.

Even more revealing was what happened when the authors reduced p53 function in irradiated tissues. Under these conditions, the RpS12-dependent Xrp1 response became even more prominent, suggesting that the competitive pathway can compensate, at least partially, when the canonical DDR is weakened. But the compensation came at a cost. Inhibition of p53 resulted in the persistence of DNA damage after irradiation, which the authors detected through the accumulation of γH2Av, the fly equivalent of γH2AX, a phosphorylated histone variant widely used as a marker for DNA double-strand breaks. Persistent γH2Av signaling indicated that breaks that should have been repaired—or the cells carrying them—were lingering in the tissue.

Taken together, these results support a model in which Xrp1 limits the accumulation of abnormal cells arising from genotoxicity through two complementary mechanisms. In the acute phase, acting as a p53 effector, it promotes the transcriptional response to damage and the apoptotic removal of heavily injured cells. In the later phase, acting in an RpS12-dependent, p53-independent manner consistent with cell competition, it contributes to the elimination of cells in which DNA repair failed to restore a normal genome. The two mechanisms are not redundant so much as sequential and overlapping, with the competitive pathway becoming more prominent precisely when the DDR is compromised.

The evolutionary implications extend well beyond the fly. Both p53 and the core machinery of the DNA damage response are conserved from insects to mammals, and cell competition has been documented in mammalian tissues as well. If Xrp1-like mechanisms operate in vertebrates, the study suggests that the tumor-suppressing power of p53 may depend not only on the genes it directly controls but also on how those genes hand off responsibility to surveillance systems that operate on longer timescales. A cell that escapes p53-mediated apoptosis after irradiation or chemotherapy might still be vulnerable to competitive elimination—unless it also acquires mutations that disable the competition pathway, a possibility that could help explain why tumors so often exhibit defects in multiple quality-control systems simultaneously.

The work also carries practical resonance for cancer treatment. Many therapies, including radiation and several classes of chemotherapy, act by inflicting DNA damage on dividing cells, relying on the patient’s own DDR and tissue surveillance to finish the job. The finding that p53 inhibition allows DNA damage to persist in fly tissues—while simultaneously shifting the burden onto an RpS12-dependent competitive mechanism—illustrates how the genetic context of a cell shapes its fate after genotoxic insult. Understanding the handoff between the acute DDR and cell competition, and the central role that Xrp1 plays in both, may therefore illuminate not only how genomes are protected during normal development but also why some damaged cells survive, persist, and ultimately seed disease.

Subject of Research: The dual roles of the Drosophila protein Xrp1 in the DNA damage response and cell competition

Article Title: Dual contributions of Xrp1 to genome integrity through the DNA damage response and cell competition

Article References: Khan, C., Rusan, N. M., & Baker, N. E. (2026). Dual contributions of Xrp1 to genome integrity through the DNA damage response and cell competition. PLOS Genetics, 22(9), e1012309. https://doi.org/10.1371/journal.pgen.1012309

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012309

Keywords: Xrp1, p53, DNA damage response, cell competition, Drosophila, RpS12, genome integrity, apoptosis, ribosome biogenesis, tumor suppression, gamma-H2Av, PLOS Genetics

The factor in question is DAF-16, the nematode worm Caenorhabditis elegans equivalent of the mammalian FOXO family of transcription factors. DAF-16 sits at the bottom of the insulin/IGF signalling pathway, a nutrient-sensing cascade whose reduction reliably extends lifespan across the animal kingdom. When insulin-like signals are low, DAF-16 accumulates in the nucleus and switches on batteries of genes involved in stress resistance, detoxification and metabolic remodelling. Because DNA repair is an energetically expensive undertaking, biologists have long suspected that it must be coordinated with the metabolic state of the cell, and the insulin pathway was an obvious candidate coordinator. What remained unclear was whether DAF-16 directly participates in maintaining genomic integrity or merely influences it indirectly through general stress physiology.

To answer that question, the team subjected worms with altered insulin signalling to genotoxic stress, including ionising radiation, and then measured how well the animals repaired the resulting lesions. The results were striking. Under conditions of reduced insulin/IGF signalling, when DAF-16 is active, the expression of DNA damage response repair genes was maintained at a higher level, and damaged DNA was repaired more promptly. Using chromatin immunoprecipitation-style approaches to examine promoter occupancy, the researchers found that activated DAF-16 binds directly to the regulatory regions of DDR genes, demonstrating that the transcription factor is not a passive bystander but an active, sequence-specific regulator of the repair programme.

This direct promoter binding is the mechanistic heart of the study. It means that when insulin signalling drops, DAF-16 enters the nucleus and physically parks itself on the genes encoding repair proteins, holding them in a state of readiness. Should a double-strand break or other lesion occur, the repair machinery is already being produced at elevated levels, allowing the cell to respond without the delay that would otherwise be required to ramp up gene expression from scratch. In effect, low insulin signalling pre-arms the genome’s emergency response, a configuration that makes evolutionary sense for an organism facing starvation or other stresses that also increase the risk of DNA damage.

One of the study’s most important findings concerns where in the animal DAF-16 operates. C. elegans contains two broadly distinct cellular compartments: the mitotic and meiotic germ cells that produce sperm and eggs, and the post-mitotic somatic cells that make up the body. The researchers determined that DAF-16 functions in both. In the soma, its activity supports the integrity of cells that can no longer divide and must simply endure damage for the remainder of the animal’s life. In the germline, its role is arguably even more critical, because the genome passed to the next generation must be protected from mutations that would become permanent heritable changes. The finding that a single nutrient-responsive transcription factor safeguards both compartments suggests that the insulin pathway coordinates genome maintenance across the entire organism rather than in a tissue-specific fashion.

The study then drilled down into the molecular fine print of DAF-16 itself. Like its mammalian FOXO cousins, DAF-16 exists as several protein isoforms generated by alternative splicing, each with slightly different sequence features and, presumably, different regulatory targets. When the team tested these isoforms individually, they discovered a clear division of labour: the DAF-16(d/f) isoform, but not the DAF-16(a) isoform, is essential for maintaining germline genome integrity. This isoform specificity is more than a technical curiosity. It implies that the different FOXO variants carved out by evolution are not interchangeable generalists but specialised tools, and it offers a potential explanation for why mammals maintain multiple FOXO genes with overlapping yet distinct functions in stress responses, metabolism and tumour suppression.

How, mechanically, does DAF-16 enhance the DNA damage response? The researchers found that the bulk of the enhancement flows through the canonical DDR components themselves, the conserved sensor and effector proteins such as the ATM-like kinases and the downstream repair pathways including homologous recombination and non-homologous end joining that mend double-strand breaks. By keeping the expression of these core components elevated, DAF-16 strengthens the primary repair machinery. Interestingly, however, the analysis revealed a secondary contribution from apoptosis, the programmed suicide of severely damaged cells. In the germline, cells whose genomes are too badly damaged to repair are normally eliminated as a failsafe, and DAF-16 activation appears to support this clearance pathway as well, albeit to a lesser extent than direct repair. Genome maintenance, in other words, is achieved through a two-pronged strategy: fix what can be fixed, and remove what cannot.

The evolutionary implications of the work are considerable. FOXO transcription factors are among the most conserved regulators of longevity known, operating in organisms from fruit flies to humans, and mammalian FOXO proteins have previously been implicated in DNA repair and tumour suppression. By establishing a direct, mechanistic role for DAF-16 in the DDR of C. elegans, the New Delhi team demonstrates that this function is conserved across the evolutionary divide separating worms and mammals. The study thus closes a conceptual loop in the biology of ageing: the same nutrient-sensing pathway that determines how long an animal lives also determines how faithfully its cells preserve the genetic instructions that make life possible in the first place. Longevity and genome stability, it turns out, are two faces of the same coin.

There are also practical horizons. Because reduced insulin/IGF signalling is a proven longevity intervention, and because DAF-16/FOXO sits at its downstream end, the new findings suggest that some of the health benefits of dampening insulin signalling may derive not from metabolic changes alone but from a strengthened capacity to repair DNA. In humans, where genomic instability underlies cancers, premature ageing syndromes and age-related tissue decline, understanding how FOXO activity could be tuned to bolster the DDR without unwanted side effects becomes an attractive pharmacological goal. The worm, with its transparent body, rapid life cycle and precisely mapped cell lineages, remains the ideal proving ground for such ideas.

For now, the study stands as a reminder that the molecules biologists thought they had categorised often harbour unexpected day jobs. DAF-16 earned its fame as a lifespan determinant, a switch that, when flipped by scarcity, extends life in the nematode. The new work shows that the same switch also keeps the genome intact under assault from radiation and other genotoxic insults, in both the cells of the body and the cells destined to become the next generation. In linking the insulin pathway, transcriptional regulation and the DNA damage response into a single coherent circuit, Devendran, Rautela, Sarkar, Mukhopadhyay and their colleagues have provided mechanistic insight into how an animal balances the energy demands of repair with the imperative of survival, and how evolution has wired the perception of nutrients directly into the defence of the genetic code itself.

Subject of Research: Role of DAF-16/FOXO in maintaining genome integrity through the DNA damage response in C. elegans

Article Title: DAF-16/FOXO maintains genome integrity following genotoxic stress

Article References: Devendran, O., Rautela, U., Sarkar, G. C., Ranjisha, K., Mittal, R., Bala, R., Goyala, A., & Mukhopadhyay, A. (2026). DAF-16/FOXO maintains genome integrity following genotoxic stress. BMC Biology. https://doi.org/10.1186/s12915-026-02755-9

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02755-9

Keywords: DAF-16, FOXO, DNA damage response, genome integrity, C. elegans, insulin/IGF signalling, DNA repair, germline, ageing, genotoxic stress, BMC Biology, maintains